73 related articles for article (PubMed ID: 28125865)
1. Comparison Between Two Detection Methods for HPV16, HPV18 and P16Ink4a Biomarkers in Diagnosis of Abnormal Cervical Cytology.
Khazaei S; Izadi B; Mirbahari SG; Madani SH; Malek Khosravi Sh; Emami Alagha M; Sajadimajd S
Asian Pac J Cancer Prev; 2016 Dec; 17(12):5223-5227. PubMed ID: 28125865
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran.
Ghaffari SR; Sabokbar T; Mollahajian H; Dastan J; Ramezanzadeh F; Ensani F; Yarandi F; Mousavi-Jarrahi A; Mohagheghi MA; Moradi A
Asian Pac J Cancer Prev; 2006; 7(4):529-32. PubMed ID: 17250423
[TBL] [Abstract][Full Text] [Related]
3. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
Reuschenbach M; Clad A; von Knebel Doeberitz C; Wentzensen N; Rahmsdorf J; Schaffrath F; Griesser H; Freudenberg N; von Knebel Doeberitz M
Gynecol Oncol; 2010 Oct; 119(1):98-105. PubMed ID: 20619445
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection.
Pientong C; Ekalaksananan T; Kongyingyoes B; Kritpetcharat O; Swadpanich U; Pengsa P; Yuenyao P
Diagn Cytopathol; 2004 Oct; 31(4):235-42. PubMed ID: 15452898
[TBL] [Abstract][Full Text] [Related]
5. The immunohistochemical detection of P16 and HPV L1 capsid protein on cell block sections from residual PapSpin liquid-based gynecology cytology specimens as a diagnostic and prognostic tool.
Haltas H; Bayrak R; Yenidunya S; Yildirim U
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1588-95. PubMed ID: 23111976
[TBL] [Abstract][Full Text] [Related]
6. P16INK4a as an adjunct marker in liquid-based cervical cytology.
Sahebali S; Depuydt CE; Segers K; Moeneclaey LM; Vereecken AJ; Van Marck E; Bogers JJ
Int J Cancer; 2004 Mar; 108(6):871-6. PubMed ID: 14712490
[TBL] [Abstract][Full Text] [Related]
7. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions.
Huang MZ; Li HB; Nie XM; Wu XY; Jiang XM
Diagn Cytopathol; 2010 Aug; 38(8):573-8. PubMed ID: 19941368
[TBL] [Abstract][Full Text] [Related]
8. Interpretation of p16(INK4a) /Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology.
Allia E; Ronco G; Coccia A; Luparia P; Macrì L; Fiorito C; Maletta F; Deambrogio C; Tunesi S; De Marco L; Gillio-Tos A; Sapino A; Ghiringhello B
Cancer Cytopathol; 2015 Apr; 123(4):212-8. PubMed ID: 25534957
[TBL] [Abstract][Full Text] [Related]
9. [The p16INK4A mRNA transcripts estimation in cervical smear with different degrees of cervical dysplasia].
Janušicová V; Kapustová I; Zúbor P; Slezák P; Kajo K; Lasabová Z; Plank L; Danko J
Ceska Gynekol; 2012 Jun; 77(3):245-50. PubMed ID: 22779728
[TBL] [Abstract][Full Text] [Related]
10. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
11. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.
Vrdoljak-Mozetič D; Krašević M; Verša Ostojić D; Štemberger-Papić S; Rubeša-Mihaljević R; Bubonja-Šonje M
Cytopathology; 2015 Feb; 26(1):10-8. PubMed ID: 24261348
[TBL] [Abstract][Full Text] [Related]
12. Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay.
Nilyanimit P; Chansaenroj J; Karalak A; Laowahutanont P; Junyangdikul P; Poovorawan Y
PeerJ; 2017; 5():e3910. PubMed ID: 29038761
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
15. Molecular testing of human papillomavirus in cervical specimens.
Gazzaz FB
Saudi Med J; 2007 Dec; 28(12):1810-8. PubMed ID: 18060207
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a new p16(INK4A) ELISA test and a high-risk HPV DNA test for cervical cancer screening: results from proof-of-concept study.
Mao C; Balasubramanian A; Yu M; Kiviat N; Ridder R; Reichert A; Herkert M; von Knebel Doeberitz M; Koutsky LA
Int J Cancer; 2007 Jun; 120(11):2435-8. PubMed ID: 17294450
[TBL] [Abstract][Full Text] [Related]
17. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening.
Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM
Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930
[TBL] [Abstract][Full Text] [Related]
19. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
20. [P16(INK4alpha)/Ki-67 immunocytochemical dual staining for detection of cervical lesions associated to papillomavirus infection].
Toro de Méndez M; Ferrández Izquierdo A; Llombart-Bosch A
Invest Clin; 2014 Sep; 55(3):238-48. PubMed ID: 25272523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
